Género y uso de medicamentos ansiolíticos e hipnóticos en España

Referencias bibliográficas

• Bakken, Marit Stordal; Engeland, Anders; Engesæter, Lars B.; Ranhoff, Anette Hylen; Hunskaar, Steinar y Ruths, Sabine. 2014. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. European Journal of Clinical Pharmacology, 70(7): 873-880.
• Bejarano Romero, Ferran; Piñol Moreso, Josep Lluís; Mora Gilabert, Nuria; Claver Luque, Pere; Brull López, Núria y Basora Gallisa, Josep. 2008. Elevado consumo de benzodiacepinas en mujeres ancianas asignadas a centros de salud urbanos de atención primaria. Atención Primaria, 40(12): 617-621.
• Bernardy, Nancy C.; Lund, Brian C.; Alexander, Bruce; Jenkyn, Aaaron B.; Schnurr, Paula P. y Friedman, Matthew J. 2012. Gender differences in prescribing among veterans diagnosed with Postraumatic Stress Disorder. Journal of General Internal Medicine, 28(S2): S542-S548.
• Billioti de Gage, Sophie; Moride, Yola; Ducruet, Thierry; Kurth, Tobias; Verdoux, Hélène; Tournier, Marie; Pariente, Antoine et al. (2014). Benzodiazepine use and risk of Alzheimer’s disease: case-control study. BMJ, 349: g5205.
• Boeuf-Cazou, Olivia; Bongue, Bienvenu; Ansiau, David; Marquié, Jean-Claude y Lapeyre-Mestre, Maryse. 2011. Impact of long-term benzodiazepine use on cognitive functioning in young adults: The VISAT cohort. European Journal of Clinical Pharmacology, 67(10): 1045-1052.
• Dell’osso, Bernardo y Lader, Malcolm. 2013. Do Benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry, 28(1): 7-20.
• Demyttenaere, Koen; Bonnewyn, Anke; Bruffaerts, Ronny; de Girolamo, Giovanni; Gasquet, Isabelle; Kovess, Viviane; Haro, José María y Alonso, Jordi. 2008. Clinical factors influencing the prescription of antidepressants and benzodiazepines: Results from the European study of the epidemiology of mental disorders (ESEMeD). Journal of Affective Disorders, 110(1-2): 84-93.
• D’Incau, Paola; Barbui, Corrado; Tubini, Jacopo y Conforti, Anita. 2011. Stressful life events and social health factors in women using anxiolytics and antidepressants: An Italian observational study in community pharmacies. Gender Medicine, 8(2): 80-92.
• Donnelly, Karen; Bracchi, Robert; Hewitt, Jonathan; Routledge, Philip A. y Carter, Ben. 2017. Benzodiazepines, Zdrugs and the risk of hip fracture: A systematic review and meta-analysis. PLoS ONE, 12(4): e0174730.
• Donoghue, John y Lader, Malcolm. 2010. Usage of benzodiazepines: A review. International Journal of Psychiatry in Clinical Practice, 14(2): 78-87.
• Eaton, Nicholas R.; Keyes, Katherine. M.; Krueger, Robert F.; Balsis, Steve; Skofol, Andrew E.; Markon, Kristian E.; Grant, Bridget F. y Hasin, Deborah S. 2012. An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. Journal of Abnormal Psychology, 121(1): 282- 288.
• Ettorre, Elizabeth y Riska, Elianne. 2001. Long-term users of psychotropic drugs: embodying masculinized stress and feminized nerves. Substance Use and Misuse, 36(9-10): 1187-1211.
• Fang, Shao-Yu; Chen, Chuan-Yu; Chang, I-Shou; Wu, Erin Chia-Hsuan; Chang, Chia-Ming y Lin, Keh-Ming. 2009. Predictors of the incidence and discontinuation of longterm use of benzodiazepines: A population-based study. Drug and Alcohol Dependence, 104(1-2): 140-146.
• Fuentealba, Ricardo; Cumsille, Francisco; Araneda, Juan Carlos y Molina, Claudio. 2000. Consumo de drogas lícitas e ilícitas en Chile: resultados del estudio de 1998 y comparación con los estudios de 1994 y 1996. Revista Panamericana de Salud Pública, 7(2): 79-87.
• Goldberg, David P. y Hillier, V. F. 1979. A scaled version of the General Health Questionnaire. Psychological Medicine, 9(1): 139-145.
• Harris, Meredith G.; Burgess, Philip M.; Pirkis, Jane; Siskind, Dan; Slade, Tim y Whiteford, Harvey A. 2011. Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. The Australian and New Zealand Journal of Psychiatry, 45(3): 249-260.
• Hollingworth, Samantha A. y Siskind, Dan J. 2010. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19(3): 280-288.
• Hughes, Lloyd D.; Raitt, Neil; Riaz, Muhamed Awais; Baldwin, Sarah-Jane; Erskine, Kay y Graham Grail. 2016. Primary care hypnotic and anxiolytic prescription: Reviewing prescribing practice over 8 years. Journal of Family Medicine and Primare Care, 5: 652-657.
• Huerta, Consuelo; Abbing-Karahagopian, Victoria; Requena, Gema; Oliva, Belén; Alvarez, Yolanda; Gardarsdottir, Helga; Miret, Montserrat et al. 2016. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiology and Drug Safety, 25(S1): 56-65.
• Jacob, Louis; Rapp, Michael A. y Kostev, Karel. 2017. Longterm use of benzodiazepines in older patients in Germany: a retrospective analysis. Therapeutic Advances in Psychopharmacology, 7(6-7): 191-200.
• Karanti, Alin; Bobeck, Christian; Osterman, Marja; Kardell, Mathias; Tidemalm, Dag; Runeson, Bo; Lichtenstein, Paul y Landén, Mikael. 2015. Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients. Journal of Affective Disorders, 174: 303- 309.
• Kessler, Ronald C.; Berglund, Patricia; Demler, Olga; Jin, Robert; Merikangas, Kathleen R. y Walters, Ellen E. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62: 593-602.
• Lader, Malcom. 2011. Benzodiazepines revisited-will we ever learn? Addiction, 106(12): 2086-2109.
• Lader, Malcolm; Tylee, Andre y Donoghue, John. 2009. Withdrawing benzodiazepines in Primary Care. CNS Drugs, 23(1): 19-34.
• Linnet, Kristjan; Gudmundsson, Larus S.; Birgisdottir, Frida G.; Sigurdsson, Emil L.; Johannsson, Magnus; Tomasdottir, Marget O. y Sigurdsson, Johan A. 2016. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. BMC Family Practice, 17: 69.
• Louvet, Steve; Ischayek, Michelle y Danoff, Rob. 2015. The current role of long-term Benzodiazepines for the treatment of Generalized anxiety. Osteopathic Family Physician, 7(1): 19-25.
• Lugoboni, Fabio; Mirijello, Antonio; Faccini, Marco; Casari, Rebeca; Cossari, Anthony; Musi, Gessica; Bissoli, Giorgia et al. 2014. Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug and Alcohol Dependence, 142: 105-109.
• Mendonça Alvarenga, Jussara; de Loyola Filho, Antonio Ignacio; Araújo Firmo, Josélia Oliveira; Lima-Costa, Maria Fernanda y Uchoa, Elizabeth. 2008. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: The Bambuí Health and Aging Study (BHAS). Revista Brasileira de Psiquiatría, 30(1): 7-11.
• Ministerio de Sanidad, Servicios Sociales e Igualdad. 2015. Consumo, percepciones y opiniones ante las drogas. Consultado el 14/01/2016. www.pnsd.msssi.gob.es/ profesionales/sistemasInformacion/sistemaInformacion/ pdf/2015_Informe_EDADES.pdf.
• Ministerio de Sanidad, Servicios Sociales e Igualdad. 2016. EDADES 2015-16 Encuesta sobre Alcohol y Drogas en España. Consultado el 20 de/06/2017. www.pnsd. msssi.gob.es/profesionales/sistemasInformacion/ sistemaInformacion/pdf/2015_EDADES__Informe_.pdf.
• Palmaro, Aurore; Dupouya, Julie y Lapeyre-Mestrea, Maryse. 2015. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. European Neuropsychopharmacology, 25(10): 1566-1577.
• Pariente, Antoine; Billioti de Gage, Sophie; Moore, Nicholas y Bégaud, Bernard. 2016. The Benzodiazepine–dementia disorders link: current state of knowledge. CNS Drugs, 30: 1-7.
• Parsaik, Ajay K.; Mascarenhas, Soniya S.; Khosh-Chashm, Darrow; Hashmi, Aqeel; John, Vineetf; Okusaga, Olaoluwa y Singh, Balwinder. 2016. Mortality associated with anxiolytic and hypnotic drugs—A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry, 50(6): 520-533.
• Pelfrene, Edwin; Vlerick, Peter; Moreau, Michel; Mak, Rudolf P.; Kornitzerc, Marcel y De Backer, Guy. 2004. Use of benzodiazepine drugs and perceived job stress in a Cohort of working men and women in Belgium. Results from the BELSTRESS-study. Social Science & Medicine, 59(2): 433-442.
• Pérez Andrés, Cristina. 1988. Mujer, derechos humanos y salud. Revista Española de Salud Pública, 72: 87-89.
• Romo, Nuria; Vega, Armando; Meneses, Carmen; Gil, Eugenia; Markez, Iñaki y Poo, Mónica. 2003. Sobre el malestar y la prescripción: un estudio sobre los usos de psicofármacos por las mujeres. Revista Española de Drogodependencias, 28(4): 372-379.
• Rosman, Sophia; Le Vaillant, Marc y Pelletier-Fleury, Nathalie. 2011. Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study. BMC Family Practice, 12: 28.
• Ruiz-Cantero, María T. y Verdú-Delgado, María. 2004. Sesgo de género en el esfuerzo terapéutico. Gaceta Sanitaria, 18(S1): 118-125.
• Simoni-Bastilla, Linda. 1998. Gender and psychotopic drug use. Medical Care, 36(1): 88-94.
• Tamburin, Stefano; Federico, Angela; Faccini, Marco; Casari, Rebecca; Morbioli, Laura; Sartore, Valentina; Mirijello, Antonio et al. 2017. Determinants of quality of life in highdose benzodiazepine misusers. International Journal of Environmental Research and Public Health, 14(38): 1-11.
• Tannenbaum, Cara; Paquette, Amélie; Hilmer, Sarah; HolroydLeduc, Heyna y Carnahan, Ryan. 2012. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging, 29(8): 639-658.
• Van der Heyden, J. H. A.; Gisle, L.; Hesse, E.; Demarest, S.; Drieskens, S. y Tafforeau, J. 2009. Gender differences in the use of anxiolytics and antidepressants: a population based study. PDS. Pharmacoepidemiology & Drugs Safety, 18(11): 1101-1110.
• Vicente Sánchez, María Pilar; Macías Saint-Gerons, Diego; Fuente Honrubia, Cesar; González Bermejo, Diana; Montero Corominas, Dolores y Catalá-López, F. 2013. Evolución del uso de medicamentos ansiolíticos e hipnóticos en España durante el periodo 2000-2011. Revista Española de Salud Pública, 87(3): 247-255.